The long-term objective of this project is to understand the role of MelCAM and its complementary ligand in cell-cell adhesion. MelCAM is a recently discovered member of the immunoglobulin superfamily of CAMs, which shows dramatically elevated expression in many melanoma and breast cancer cell lines. Structure-function analysis of MelCAM and its 95 kDa ligand will use protein chemical and molecular biology methods to study both natural proteins from melanoma cells and recombinants expressed in insect cells, E. coli, and stably-transfected human cells. Methods will include: HPLC peptide mapping, N-terminal sequencing, mass spectrometry, microcalorimetry, circular dichroism, immunological methods, and cell binding assays. The functionally-important interactions that will be studied in this project are: (1) lateral association of MelCAM within a single plasma membrane (cis homodimers); (2) heterotypic intercellular binding to a novel 95 kDa ligand, and (3) association with the cytoskeleton. The overall hypothesis is that heterotypic intercellular association with MelCAM with its 95 kDa ligand forms important cell-cell adhesions that play important, but poorly defined, roles in primary tumor growth as well as the invasive stages of metastasis. A specific hypothesis that will be directly tested is that these moderate affinity intercellular interactions are dependent upon the oligomeric state of MelCAM within the cell membrane, i.e., a cis MelCAM homodimer is essential for adhesion. In addition, association of MelCAM with the cytoskeleton does occur and is likely to be involved in intercellular adhesion and/or transmembrane signaling. Signal transduction and/or interaction with the cytoskeleton may involve phosphorylation of the MelCAM cytoplasmic domain.
The specific aims of this proposal are: (1) clone and characterize the heterotypic 95 kDa ligand; (2) map and characterize MelCAM binding sites; and (3) identify cytoskeletal proteins associated with MelCAM and define their role. MelCAM expression correlates closely with the transformed phenotype; only trace expression occurs on normal melanocytes in vivo, while very high MelCAM expression is observed in aggressively growing tumors and in most melanoma cell lines. The MelCAM-ligand adhesion system is both essential and sufficient for cell-cell aggregation of melanoma cells. This project will produce a detailed understanding of the structural and functional properties of MelCAM-mediated cell-cell adhesion, which should provide critical insights concerning its importance during tumor progression.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Biochemistry Study Section (BIO)
Program Officer
Mohla, Suresh
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wistar Institute
United States
Zip Code
Trebak, M; Begg, G E; Chong, J M et al. (2001) Oligomeric state of the colon carcinoma-associated glycoprotein GA733-2 (Ep-CAM/EGP40) and its role in GA733-mediated homotypic cell-cell adhesion. J Biol Chem 276:2299-309
Lechner, M S; Begg, G E; Speicher, D W et al. (2000) Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential. Mol Cell Biol 20:6449-65
Peng, H; Begg, G E; Schultz, D C et al. (2000) Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions. J Mol Biol 295:1139-62
Zuo, X; Speicher, D W (2000) Quantitative evaluation of protein recoveries in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:3035-47
Trebak, M; Chong, J M; Herlyn, D et al. (1999) Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. J Immunol Methods 230:59-70
Basak, S; Speicher, D; Eck, S et al. (1998) Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90:691-7
Sebti, S; Hamilton, A D (1997) Inhibitors of prenyl transferases. Curr Opin Oncol 9:557-61
Sebti, S M; Hamilton, A D (1997) Inhibition of Ras prenylation: a novel approach to cancer chemotherapy. Pharmacol Ther 74:103-14
Shih, I M; Speicher, D; Hsu, M Y et al. (1997) Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res 57:3835-40